Viewing Study NCT02681861


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-02-03 @ 1:17 AM
Study NCT ID: NCT02681861
Status: COMPLETED
Last Update Posted: 2017-01-10
First Post: 2016-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
Sponsor: Astellas Pharma Europe B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Subjects View
None Pharmacokinetics of ASP6294 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacodynamics View
None Pharmacokinetics View
None ASP6294 View
None Maximum tolerated dose View
None Healthy subjects View